Treatment of genital warts: Facts and controversies

Clinics in Dermatology

Volumn 28, Issue 5, 2010, Pages 546-548

  Wolf, Ronni ^a   Davidovici, Batya ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; COLPOSCOPY; CONDYLOMA ACUMINATUM; DISEASE COURSE; FEMALE; GYNECOLOGICAL EXAMINATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOW LEVEL LASER THERAPY; MALE; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; TREATMENT RESPONSE; UTERINE CERVIX BIOPSY; VULVA; WART VIRUS;

ADULT; CONDYLOMATA ACUMINATA; FEMALE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; RECURRENCE; SEXUAL PARTNERS;

EID: 77955928314     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2010.03.013     Document Type: Article

References (28)

1. Skerlev M., Grce M., Sirotkoviae-Skerlev M., Husnjak K., Lpozencic J. Human papillomavirus male genital infections: clinical variations and the significance of DNA typing. Clin Dermatol 2002, 20:173-178.
2. Mlakar B. Anoscopy could be beneficial for women with external anogenital condyloma. Eur J Obstet Gynecol Reprod Biol 2007, 133:121-122.
3. Schoenfeld A., Ziv E., Levavi H., Samra Z., Oadia J. Laser versus loop electrosurgical excision in vulvar condyloma for eradication of subclinical reservoir demonstrated by assay for 2'5' oligosynthetase human papillomavirus. Gynecol Obstet Invest 1995, 40:46-51.
4. Syed T.A., Lndin S. Topical treatment of penile condylomata acuminata with podophyllotoxin 0.3% solution, 0.3% cream and 0.15% cream. A comparative open study. Dermatology 1993, 187:30-33.
5. Padilla-Ailhaud A. Carbon dioxide laser vaporization of condyloma acuminata. J Low Genit Tract Dis 2006, 10:238-241.
6. Mayeaux E.J., Harper M.B., Barksdale W., Pope J.B. Noncervical human papillomavirus genital infections. Am Fam Physician 1995, 52:1137-1150.
7. Savoca S., Nardo L.G., Rosano T.F., D'Agosta S., Nrdo F. CO(2) laser vaporization as primary therapy for human papillomavirus lesions. A prospective observational study. Acta Obstet Gynecol Scand 2001, 80:1121-1124.
8. Lacey C.J., Goodall R.L., Tennvall G.R., et al. Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts. Sex Transm Infect 2003, 79:270-275.
9. Ault K.A. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect Dis Obstet Gynecol 2006, 14:40470.
10. Lacey C.J. Therapy for genital human papillomavirus-related disease. J Clin Virol 2005, 32(Suppl 1):S82-S90.
11. Lacey C.J., Lowndes C.M., Sah K.V. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006, 24(Suppl 3):S35-S41.
12. Gross G., Ikenberg H., Gissmann L., Hgedorn M. Papillomavirus infection of the anogenital region: correlation between histology, clinical picture, and virus type. Proposal of a new nomenclature. J Invest Dermatol 1985, 85:147-152.
13. Vandepapeliere P., Barrasso R., Meijer C.J., et al. Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination. J Infect Dis 2005, 192:2099-2107.
14. Brown D.R., Schroeder J.M., Bryan J.T., Stoler M.H., Ffe K.H. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 1999, 37:3316-3322.
15. Sheary B., Dyan L. Cervical screening and human papillomavirus. Aust Fam Physician 2005, 34:578-580.
16. Mao C., Hughes J.P., Kiviat N., et al. Clinical findings among young women with genital human papillomavirus infection. Am J Obstet Gynecol 2003, 188:677-684.
17. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997, 102:3-8.
18. Koutsky L.A., Galloway D.A., Hlmes K.K. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988, 10:122-163.
19. Herrero R., Castle P.E., Schiffman M., et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005, 191:1796-1807.
20. Moscicki A.B., Shiboski S., Broering J., et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998, 132:277-284.
21. Ho G.Y., Bierman R., Beardsley L., Chang C.J., Burk R.D. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998, 338:423-428.
22. Franco E.L., Villa L.L., Sobrinho J.P., et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999, 180:1415-1423.
23. Evander M., Edlund K., Gustafsson A., et al. Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis 1995, 171:1026-1030.
24. Rosa M.I., Fachel J.M., Rosa D.D., Medeiros L.R., Igansi C.N., Bozzetti M.C. Persistence and clearance of human papillomavirus infection: a prospective cohort study. Am J Obstet Gynecol 2008, 199:617.e1-617.e7.
25. Sycuro L.K., Xi L.F., Hughes J.P., et al. Persistence of genital human papillomavirus infection in a long-term follow-up study of female university students. J Infect Dis 2008, 198:971-978.
26. Macnab J.C., Walkinshaw S.A., Cordiner J.W., Clements J.B. Human papillomavirus in clinically and histologically normal tissue of patients with genital cancer. N Engl J Med 1986, 315:1052-1058.
27. Workowski K.A., Berman S.M. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006, 55:1-94.
28. Centers for Disease Control and Prevention. Report to Congress: prevention of genital human papillomavirus infection (Jan 2004) 2004, CDC, Atlanta (Ga).